Bilateral oedemas are a known complication, but their unilateral manifestation has been described only rarely, mostly in transplant recipients.[5,6] A less-common type of adverse event as a result of mTOR inhibitor therapy is lymphedema. The gene discussed is MTOR; the disease is lymphedema.